1. Home
  2. CMCO vs ITRM Comparison

CMCO vs ITRM Comparison

Compare CMCO & ITRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CMCO
  • ITRM
  • Stock Information
  • Founded
  • CMCO 1875
  • ITRM 2015
  • Country
  • CMCO United States
  • ITRM Ireland
  • Employees
  • CMCO N/A
  • ITRM N/A
  • Industry
  • CMCO Construction/Ag Equipment/Trucks
  • ITRM Biotechnology: Pharmaceutical Preparations
  • Sector
  • CMCO Industrials
  • ITRM Health Care
  • Exchange
  • CMCO Nasdaq
  • ITRM Nasdaq
  • Market Cap
  • CMCO 472.4M
  • ITRM 40.0M
  • IPO Year
  • CMCO 1996
  • ITRM 2018
  • Fundamental
  • Price
  • CMCO $16.39
  • ITRM $0.96
  • Analyst Decision
  • CMCO Hold
  • ITRM Strong Buy
  • Analyst Count
  • CMCO 1
  • ITRM 2
  • Target Price
  • CMCO $35.00
  • ITRM $7.00
  • AVG Volume (30 Days)
  • CMCO 365.8K
  • ITRM 517.2K
  • Earning Date
  • CMCO 07-30-2025
  • ITRM 08-13-2025
  • Dividend Yield
  • CMCO 1.71%
  • ITRM N/A
  • EPS Growth
  • CMCO N/A
  • ITRM N/A
  • EPS
  • CMCO N/A
  • ITRM N/A
  • Revenue
  • CMCO $963,027,000.00
  • ITRM N/A
  • Revenue This Year
  • CMCO $10.17
  • ITRM N/A
  • Revenue Next Year
  • CMCO $33.08
  • ITRM $270.19
  • P/E Ratio
  • CMCO N/A
  • ITRM N/A
  • Revenue Growth
  • CMCO N/A
  • ITRM N/A
  • 52 Week Low
  • CMCO $11.78
  • ITRM $0.81
  • 52 Week High
  • CMCO $41.05
  • ITRM $3.02
  • Technical
  • Relative Strength Index (RSI)
  • CMCO 58.61
  • ITRM 42.78
  • Support Level
  • CMCO $15.02
  • ITRM $0.95
  • Resistance Level
  • CMCO $15.65
  • ITRM $1.03
  • Average True Range (ATR)
  • CMCO 0.60
  • ITRM 0.04
  • MACD
  • CMCO 0.19
  • ITRM -0.00
  • Stochastic Oscillator
  • CMCO 95.87
  • ITRM 17.23

About CMCO Columbus McKinnon Corporation

Columbus McKinnon Corp is a designer, manufacturer, and marketer of intelligent motion solutions, including motion control products, technologies, automated systems, and services that efficiently and ergonomically move, lift, position, and secure materials. Its key products include hoists, crane components, precision conveyors, actuators, rigging tools, light rail workstations, and digital power and motion control systems. The company's targeted market verticals include general industries, process industries, industrial automation, and e-commerce/supply chain/warehousing among others. Geographically, the company generates a majority of its revenue from the United States and the rest from Germany, Canada, Asia Pacific, Latin America, Europe, the Middle East, and Africa.

About ITRM Iterum Therapeutics plc

Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.

Share on Social Networks: